Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

924 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Phase I trial of histone deacetylase inhibition by valproic acid followed by the topoisomerase II inhibitor epirubicin in advanced solid tumors: a clinical and translational study.
Münster P, Marchion D, Bicaku E, Schmitt M, Lee JH, DeConti R, Simon G, Fishman M, Minton S, Garrett C, Chiappori A, Lush R, Sullivan D, Daud A. Münster P, et al. Among authors: fishman m. J Clin Oncol. 2007 May 20;25(15):1979-85. doi: 10.1200/JCO.2006.08.6165. J Clin Oncol. 2007. PMID: 17513804 Clinical Trial.
Increased bioavailability of intravenous versus oral CI-1033, a pan erbB tyrosine kinase inhibitor: results of a phase I pharmacokinetic study.
Simon GR, Garrett CR, Olson SC, Langevin M, Eiseman IA, Mahany JJ, Williams CC, Lush R, Daud A, Munster P, Chiappori A, Fishman M, Bepler G, Lenehan PF, Sullivan DM. Simon GR, et al. Among authors: fishman m. Clin Cancer Res. 2006 Aug 1;12(15):4645-51. doi: 10.1158/1078-0432.CCR-05-2379. Clin Cancer Res. 2006. PMID: 16899614 Clinical Trial.
Phase I study of a novel taxane BMS-188797 in adult patients with solid malignancies.
Garrett CR, Fishman MN, Rago RR, Williams CC, Dellaportas AM, Mahany JJ, Lush RM, Dalton WS, Gollerkeri A, Cohen MB, Sullivan DM. Garrett CR, et al. Among authors: fishman mn. Clin Cancer Res. 2005 May 1;11(9):3335-41. doi: 10.1158/1078-0432.CCR-04-1494. Clin Cancer Res. 2005. PMID: 15867232 Clinical Trial.
Specific antitumour vaccine for renal cancer.
Fishman M, Antonia S. Fishman M, et al. Lancet. 2004 Feb 21;363(9409):583-4. doi: 10.1016/S0140-6736(04)15625-0. Lancet. 2004. PMID: 14987879 No abstract available.
Novel therapies for renal cell carcinoma--an update.
Fishman M, Antonia S. Fishman M, et al. Expert Opin Investig Drugs. 2003 Apr;12(4):593-609. doi: 10.1517/13543784.12.4.593. Expert Opin Investig Drugs. 2003. PMID: 12665415 Review.
924 results